SK287198B6 - Izolovaný alebo rekombinantný polynukleotid kódujúci antigénny polypeptid, expresný vektor, hostiteľská bunka, väzbová zložka, súprava a spôsob jeho použitia a expresie - Google Patents

Izolovaný alebo rekombinantný polynukleotid kódujúci antigénny polypeptid, expresný vektor, hostiteľská bunka, väzbová zložka, súprava a spôsob jeho použitia a expresie Download PDF

Info

Publication number
SK287198B6
SK287198B6 SK91-2000A SK912000A SK287198B6 SK 287198 B6 SK287198 B6 SK 287198B6 SK 912000 A SK912000 A SK 912000A SK 287198 B6 SK287198 B6 SK 287198B6
Authority
SK
Slovakia
Prior art keywords
cells
antigen
antibody
sequence
binding
Prior art date
Application number
SK91-2000A
Other languages
English (en)
Slovak (sk)
Other versions
SK912000A3 (en
Inventor
Fernando J. Bazan
Original Assignee
Schering Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25413278&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK287198(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corporation filed Critical Schering Corporation
Publication of SK912000A3 publication Critical patent/SK912000A3/sk
Publication of SK287198B6 publication Critical patent/SK287198B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SK91-2000A 1997-07-25 1998-07-24 Izolovaný alebo rekombinantný polynukleotid kódujúci antigénny polypeptid, expresný vektor, hostiteľská bunka, väzbová zložka, súprava a spôsob jeho použitia a expresie SK287198B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90090597A 1997-07-25 1997-07-25
PCT/US1998/015423 WO1999005280A1 (en) 1997-07-25 1998-07-24 Mammalian cytokine: interleukin-b30 and related reagents

Publications (2)

Publication Number Publication Date
SK912000A3 SK912000A3 (en) 2000-09-12
SK287198B6 true SK287198B6 (sk) 2010-03-08

Family

ID=25413278

Family Applications (1)

Application Number Title Priority Date Filing Date
SK91-2000A SK287198B6 (sk) 1997-07-25 1998-07-24 Izolovaný alebo rekombinantný polynukleotid kódujúci antigénny polypeptid, expresný vektor, hostiteľská bunka, väzbová zložka, súprava a spôsob jeho použitia a expresie

Country Status (29)

Country Link
EP (3) EP2233574A1 (xx)
JP (5) JP4316133B2 (xx)
KR (1) KR100666835B1 (xx)
CN (2) CN101851286A (xx)
AR (2) AR017510A1 (xx)
AT (1) ATE443142T1 (xx)
AU (1) AU741046B2 (xx)
BR (1) BR9811039A (xx)
CA (1) CA2296272C (xx)
CO (1) CO4810232A1 (xx)
CZ (1) CZ300958B6 (xx)
DE (1) DE69841161D1 (xx)
DK (2) DK2100959T3 (xx)
ES (2) ES2610483T3 (xx)
HK (1) HK1024932A1 (xx)
HU (1) HU230629B1 (xx)
ID (1) ID28114A (xx)
IL (3) IL134068A0 (xx)
LT (1) LT2100959T (xx)
MY (1) MY157028A (xx)
NO (1) NO329329B1 (xx)
NZ (1) NZ502391A (xx)
PE (1) PE20000183A1 (xx)
PL (1) PL197150B1 (xx)
PT (2) PT2100959T (xx)
SK (1) SK287198B6 (xx)
TW (1) TWI237057B (xx)
WO (1) WO1999005280A1 (xx)
ZA (1) ZA986596B (xx)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6060284A (en) 1997-07-25 2000-05-09 Schering Corporation DNA encoding interleukin-B30
DE69834938T2 (de) * 1997-10-23 2007-02-01 Nippon Institute For Biological Science, Oume Granulozyten-kolonie-stimulierender faktor aus der katze
WO1999040195A1 (en) * 1998-02-06 1999-08-12 Schering Corporation Mammalian receptor proteins; related reagents and methods
DE69942607D1 (de) * 1998-04-14 2010-09-02 Chugai Pharmaceutical Co Ltd Neues cytokinartiges protein
EP1905832A3 (en) 1999-09-09 2009-09-09 Schering Corporation Mammalian interleukin-12 P40 and interleukin B30, combinations thereof, antibodies, uses in pharmaceutical compositions
US7090847B1 (en) 1999-09-09 2006-08-15 Schering Corporation Mammalian cytokines; related reagents and methods
ES2300276T5 (es) * 1999-09-09 2017-06-02 Merck Sharp & Dohme Corp. P40 de interleuquina-12 de mamífero e interleuquina B30. Sus combinaciones. Anticuerpos. Usos en composiciones farmacéuticas
AU2005202420B2 (en) * 1999-09-09 2008-08-07 Merck Sharp & Dohme Corp. Mammalian cytokines; related reagents and methods
EP2108660A1 (en) 2002-10-30 2009-10-14 Genentech, Inc. Inhibition of IL-17 production
CA2525184C (en) 2003-05-09 2012-10-30 Centocor, Inc. Il-23p40 specific immunoglobulin derived proteins, compositions, methods and uses
WO2005108425A1 (en) * 2004-05-10 2005-11-17 Cytos Biotechnology Ag Il-23 p19 antigen array and uses thereof
AR051444A1 (es) 2004-09-24 2007-01-17 Centocor Inc Proteinas derivadas de inmunoglobulina especifica de il-23p40, composiciones, epitopos, metodos y usos
CN101252951B (zh) 2005-06-30 2011-12-21 森托科尔公司 抗il-23抗体、组合物、方法和用途
EP1971366B1 (en) 2005-12-29 2014-07-30 Janssen Biotech, Inc. Human anti-il-23 antibodies, compositions, methods and uses
US7910703B2 (en) 2006-03-10 2011-03-22 Zymogenetics, Inc. Antagonists to IL-17A, IL-17F, and IL-23P19 and methods of use
AU2007260787A1 (en) 2006-06-13 2007-12-21 Zymogenetics, Inc IL-17 and IL-23 antagonists and methods of using the same
TWI426918B (zh) 2007-02-12 2014-02-21 Merck Sharp & Dohme Ｉｌ-２３拮抗劑於治療感染之用途
WO2009068625A2 (en) 2007-11-27 2009-06-04 Ablynx N.V. Amino acid sequences directed against her2 and polypeptides comprising the same for the treatment of cancers and/or tumors
CN104628855A (zh) 2008-05-05 2015-05-20 诺维莫尼公司 抗il-17a/il-17f交叉反应性抗体及其使用方法
RU2605318C2 (ru) 2009-05-05 2016-12-20 Новиммун С.А. Анти-il-17f антитела и способы их применения
JO3244B1 (ar) 2009-10-26 2018-03-08 Amgen Inc بروتينات ربط مستضادات il – 23 البشرية
EP3456740A1 (en) 2010-11-04 2019-03-20 Boehringer Ingelheim International GmbH Anti-il-23 antibodies
EP4039275A1 (en) 2012-05-03 2022-08-10 Boehringer Ingelheim International GmbH Anti-il-23p19 antibodies
EP3689369A1 (en) 2013-03-15 2020-08-05 Amgen, Inc Methods for treating psoriasis using an anti-il-23 antibody
NZ712294A (en) 2013-03-15 2020-04-24 Amgen Inc Methods for treating crohn’s disease using an anti-il23 antibody
US10507241B2 (en) 2014-07-24 2019-12-17 Boehringer Ingelheim International Gmbh Biomarkers useful in the treatment of IL-23A related diseases
SG11201701423RA (en) 2014-09-03 2017-03-30 Boehringer Ingelheim Int Compound targeting il-23a and tnf-alpha and uses thereof
KR20180063127A (ko) 2015-09-17 2018-06-11 암젠 인크 Il23 경로 바이오마커를 사용한, il23-길항제에 대한 임상 반응의 예측
CN108472367A (zh) 2015-12-22 2018-08-31 美国安进公司 作为对il23拮抗剂的临床应答的预测因子的ccl20
AU2019300491A1 (en) 2018-07-13 2021-03-04 Astrazeneca Collaboration Ventures, Llc Treating ulcerative colitis with brazikumab
WO2020104943A2 (en) 2018-11-20 2020-05-28 Janssen Biotech, Inc. Safe and effective method of treating psoriasis with anti-il-23 specific antibody
AU2020279987A1 (en) 2019-05-23 2021-11-18 Janssen Biotech, Inc. Method of treating inflammatory bowel disease with a combination therapy of antibodies to IL-23 and TNF alpha
AU2020409124A1 (en) 2019-12-20 2022-06-30 Novarock Biotherapeutics, Ltd. Anti-interleukin-23 p19 antibodies and methods of use thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2046920B1 (xx) 1969-06-19 1974-05-03 Citizen Watch Co Ltd
US3940475A (en) 1970-06-11 1976-02-24 Biological Developments, Inc. Radioimmune method of assaying quantitatively for a hapten
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
DE3382317D1 (de) 1982-03-15 1991-07-25 Schering Corp Hybride dns, damit hergestellte bindungszusammensetzung und verfahren dafuer.
US4659678A (en) 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4859609A (en) 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
US5891680A (en) * 1995-02-08 1999-04-06 Whitehead Institute For Biomedical Research Bioactive fusion proteins comprising the p35 and p40 subunits of IL-12
DE69942607D1 (de) * 1998-04-14 2010-09-02 Chugai Pharmaceutical Co Ltd Neues cytokinartiges protein

Also Published As

Publication number Publication date
IL134068A0 (en) 2001-04-30
IL205765A0 (en) 2011-07-31
JP2010011863A (ja) 2010-01-21
PL338262A1 (en) 2000-10-09
ES2610483T3 (es) 2017-04-27
JP2001511347A (ja) 2001-08-14
CA2296272C (en) 2012-03-13
CO4810232A1 (es) 1999-06-30
AR017510A1 (es) 2001-09-12
NO20000343L (no) 2000-03-24
IL134068A (en) 2010-11-30
CN1271387A (zh) 2000-10-25
ES2331762T3 (es) 2010-01-14
NO329329B1 (no) 2010-09-27
EP2100959B1 (en) 2016-12-07
ATE443142T1 (de) 2009-10-15
HUP0004019A3 (en) 2003-08-28
JP4316133B2 (ja) 2009-08-19
PL197150B1 (pl) 2008-03-31
AU8589498A (en) 1999-02-16
WO1999005280A1 (en) 1999-02-04
EP1002084A1 (en) 2000-05-24
NZ502391A (en) 2002-12-20
JP2013034480A (ja) 2013-02-21
IL205765A (en) 2015-07-30
PT1002084E (pt) 2009-12-16
CZ2000263A3 (cs) 2000-06-14
BR9811039A (pt) 2000-08-08
AU741046B2 (en) 2001-11-22
AR086483A2 (es) 2013-12-18
EP2100959A2 (en) 2009-09-16
KR100666835B1 (ko) 2007-01-11
CA2296272A1 (en) 1999-02-04
PE20000183A1 (es) 2000-03-11
ZA986596B (en) 1999-02-08
EP1002084B1 (en) 2009-09-16
EP2233574A1 (en) 2010-09-29
LT2100959T (lt) 2017-01-10
JP2015037405A (ja) 2015-02-26
CZ300958B6 (cs) 2009-09-23
EP2100959A3 (en) 2009-10-14
CN101851286A (zh) 2010-10-06
HK1024932A1 (en) 2000-10-27
MY157028A (en) 2016-04-15
HU230629B1 (hu) 2017-04-28
DK1002084T3 (da) 2010-01-04
SK912000A3 (en) 2000-09-12
PT2100959T (pt) 2017-01-09
DE69841161D1 (de) 2009-10-29
NO20000343D0 (no) 2000-01-24
ID28114A (id) 2001-05-03
TWI237057B (en) 2005-08-01
HUP0004019A2 (en) 2001-03-28
KR20010022214A (ko) 2001-03-15
JP2005323610A (ja) 2005-11-24
DK2100959T3 (en) 2017-01-30

Similar Documents

Publication Publication Date Title
US8765914B2 (en) Interleukin-B30 proteins
KR100666835B1 (ko) 인터루킨-ｂ30의 폴리펩타이드, 이를 암호화하는 뉴클레오타이드 및 이에 대한 항체를 포함하는 약제학적 조성물
CA2343979C (en) Human interleukin-b50, therapeutic uses
JP2003500010A (ja) 哺乳動物サイトカイン；関連試薬および方法
JP2015180228A (ja) 哺乳動物サイトカイン；関連試薬
US20040192891A1 (en) Mammalian cytokines; related reagents and methods
AU773669B2 (en) Mammalian cytokine: interleukin-B30 and related reagents
MXPA00000928A (en) Mammalian cytokine:interleukin-b30 and related reagents

Legal Events

Date Code Title Description
TC4A Change of owner's name

Owner name: MERCK SHARP & DOHME CORP., RAHWAY, NJ, US

Effective date: 20121108

MK4A Patent expired

Expiry date: 20180724